促肝细胞生长物质(HSS)

促肝细胞生长物质(hepaticstimulatorysubstance,HSS)不仅能够阻止肝损伤、启动肝细胞增殖再生,而且可以部分恢复肝功能以及具有抗氧化作用,因此有较为广阔的应用前景。     

肝细胞生长因子

肝细胞生长因子吴青（中山大学生命科学学院,广州５１０２７５）关键词肝细胞生长因子１９８４年,ＭｉｃｈａＬｏｐｏｕｌｏｓ发现部分肝切除后的大鼠血浆中含有一种能刺激肝细胞ＤＮＡ合成的物质,１９８８年Ｇｏｈａｌａ从暴发性肝衰竭病人血浆中分离出类似物质。该类...     

MTT比色法测定促肝细胞生长物质对肝细胞生长的刺激活性

本实验建立了用简便的ＭＴＴ比色法对促肝细胞生长物质的促肝细胞增殖作用的测定方法,确定了实验的最适条件。与传统的３Ｈ ＴｄＲ掺入法进行比较的结果显示,ＭＴＴ比色法与３Ｈ ＴｄＲ掺入法测定结果基本相符,灵敏度相近,但消除了同位素的污染,是一个测定促肝细胞生长物质刺激肝细胞增殖活性的简便方法。     

重组腺病毒介导 HGF 修饰 ADSCs 对大鼠肝损伤模型的治疗作用

摘要 目的：建立重组腺病毒介导肝细胞生长因子 HGF 促 ADSCs 定向分化肝细胞的方法,并对其参与肝损伤修复能力进行验 证, 为作为治疗肝损伤细胞来源提供参考。 方法： 采用消化培养的方法, 分离 SD 大鼠腹股沟脂肪组织 ADSCs 细胞, 连续传代 3 次 对其进行纯化培养, 利用形态学鉴定、 流式细胞术检测 ADSCs 表面标志物方法对其间充质干细胞样特征进行鉴定, 加入成脂肪 细胞诱导液观察其分化成脂肪细胞的能力; 构建腺病毒表达 HGF 载体 Adeno-HGF-EGFP, 并转染 ADSCs 细胞, 利用免疫细胞化 学染色方法检测肝细胞标志分子表达水平; 最后建立大鼠肝损伤动物型, 观察 Adeno-HGF-EGFP 转染的 ADSCs 细胞参与肝损 伤修复能力情况。结果： 分离的 ADSCs 细胞形态较为一致, 绝大多数呈梭形, 排列不规则。流式细胞术结果显示, 该细胞表达 CD29、 CD90、 CD106 等间充质干细胞细胞表面标记物, 低表达造血干细胞细胞表面标记物 CD34、 CD45, 同时, 分离的 ADSCs 细 胞具有诱导分化成脂肪细胞能力; Adeno-HGF-EGFP 转染 ADSCs 后, AFP、 ALB、 CK18 等肝细胞特异性分子表达水平升高;经尾 静脉注射 ADSCs 细胞后, 肝损伤大鼠的 AST、 ALT、 TBIL 等分子表达水平恢复正常。结论： 建立了重组腺病毒介导肝细胞生长因 子 HGF 促 ADSCs 定向分化肝细胞的方法, 并且表达 HGF 的 ADSCs 细胞具有修复大鼠肝损伤模型能力, 这为通过细胞治疗肝损 伤提供了新的细胞来源。     

肝再生刺激因子对小鼠实验性急性肝损伤的保护机制

我们前文证明肝再生刺激因子(HSS)对小鼠实验性肝损伤有保护作用。本文进一步探讨其机制并获得如下结果:(1)HSS显著提高由CCl_4所降低肝细胞膜、线粒体膜和微粒体膜的流动性,使其上升到对照水平。(2)HSS使CCl_4所致的肝组织丙二醛升高幅度降低。(3)HSS使CCl_4所致的肝组织谷胱甘肽降低的含量回升。(4)HSS能刺激受CCl_4损伤的肝再生,促进肝细胞合成DNA和~3H-TdR掺入肝细胞DNA。这些结果提示,HSS具有抗氧化作用,能抗CCl_4所产生的自由基对膜脂质的过氧化。此外还加强肝细胞本身抗氧化能力和促进受损肝脏再生。这些保肝机制可能相互联系。     

中药博落回的药理实验研究

博落回对四氯化碳、半乳糖胺所致急性肝损伤模型,均有显著改善肝脏功能作用;对四氯化碳所致慢性肝损伤大鼠模型,博落回可显著降低血清LDH水平。降低动物死亡率。提高血清A/G比值,有效保护肝细胞胰。抑制肝脏纤维化;博落回还可显著增强T和B淋巴细胞功能。     

我国促肝细胞生长因子的研究和应用

促肝细胞生长因子具有促进细胞增殖和生长的作用,国内外研究较多。我国对肝细胞生 长因子的研究和应用主要集中在肝源性促肝细胞生长因子上。在总结国内学者历年研究成果的 基础上,结合我国生产和应用的实际情况,对促肝细胞生长因子的来源、结构、理化性质、生产及 应用情况进行了综述,有助于更深入研究。     

Kupffer细胞在APAP所致肝损伤中作用研究进展

对乙酰氨基酚所致肝损伤(acetaminophen-induced liver injury, AILI)是一类普遍的药物源性肝损伤(drug-induced liver injury, DILI),是造成急性肝衰竭(acute liver failure, AIF)的主要原因。Kupffer细胞为肝脏固有巨噬细胞,是机体先天免疫重要组成部分。Kupffer具有促炎和抗炎的双重作用,通过识别损伤相关模式分子(damage-associated molecular patterns, DAMPs)激活细胞内炎症信号,释放促炎因子、抗炎因子和趋化因子。Kupffer在AILI氧化应激、细胞招募、炎症反应、肝再生和纤维化等过程起着重要作用,对AILI的发生、发展及转归有着重要的影响。     

microRNA在对乙酰氨基酚所致肝损伤中抗损伤作用研究进展

药物引起的急性肝损伤(drug-induced liver injury,DILI)是导致肝衰竭的重要原因,其中以对乙酰氨基酚(acetaminophen,APAP)最常见。microRNA为一类非编码小RNA,在肝脏中具有重要的生物学功能,其对APAP所致肝损伤过程中代谢损伤、炎症发展以及肝再生等病理过程具有显著调控作用,对APAP所致肝损伤(acetaminophen-induced liver injury,AILI)发生发展产生重要影响。APAP所致的肝损伤能引起不同种类microRNA含量的变化,其中多种microRNA表达含量的变化能抑制炎症的发展,减轻肝损伤程度,对肝组织起保护作用。这属于机体应对损伤刺激时所表现的自我保护性机制。本文对在AILI中具有抗损伤作用的microRNA相关研究进行综述,并总结microRNA作用靶点与调控机制。     

重组腺病毒介导HGF修饰ADSCs对大鼠肝损伤模型的治疗作用

目的：建立重组腺病毒介导肝细胞生长因子HGF促ADSCs 定向分化肝细胞的方法,并对其参与肝损伤修复能力进行验证,为作为治疗肝损伤细胞来源提供参考。方法：采用消化培养的方法,分离SD 大鼠腹股沟脂肪组织ADSCs 细胞,连续传代3 次对其进行纯化培养,利用形态学鉴定、流式细胞术检测ADSCs 表面标志物方法对其间充质干细胞样特征进行鉴定,加入成脂肪细胞诱导液观察其分化成脂肪细胞的能力;构建腺病毒表达HGF载体Adeno-HGF-EGFP,并转染ADSCs 细胞,利用免疫细胞化学染色方法检测肝细胞标志分子表达水平;最后建立大鼠肝损伤动物模型,观察Adeno-HGF-EGFP 转染的ADSCs 细胞参与肝损伤修复能力情况。结果：分离的ADSCs 细胞形态较为一致,绝大多数呈梭形,排列不规则。流式细胞术结果显示,该细胞表达CD29、CD90、CD106 等间充质干细胞细胞表面标记物,低表达造血干细胞细胞表面标记物CD34、CD45,同时,分离的ADSCs 细胞具有诱导分化成脂肪细胞能力;Adeno-HGF-EGFP 转染ADSCs后,AFP、ALB、CK18 等肝细胞特异性分子表达水平升高;经尾静脉注射ADSCs 细胞后,肝损伤大鼠的AST、ALT、TBIL 等分子表达水平恢复正常。结论：建立了重组腺病毒介导肝细胞生长因子HGF促ADSCs定向分化肝细胞的方法,并且表达HGF的ADSCs 细胞具有修复大鼠肝损伤模型能力,这为通过细胞治疗肝损伤提供了新的细胞来源。     

Melatonin and its protective role in attenuating warm or cold hepatic ischaemia/reperfusion injury

Although the liver is the only organ with regenerative capacity, various injury factors induce irreversible liver dysfunction and end‐stage liver disease. Liver resection and liver transplantation (LT) are effective treatments for individuals with liver failure, liver cirrhosis and liver cancers. The remnant or transplanted liver tissues will undergo hepatic ischaemia/reperfusion (IR), which leads to oxidative stress, inflammation, immune injury and liver damage. Moreover, systemic ischaemia induced by trauma, stroke, myocardial ischaemia, haemorrhagic shock and other injury factors also induces liver ischaemia/reperfusion injury (IRI) in individuals. Hepatic IRI can be divided into warm IRI, which is induced by liver surgery and systemic ischaemia, and cold IRI, which is induced by LT. Multiple studies have shown that melatonin (MT) acts as an endogenous free radical scavenger with antioxidant capacity and is also able to attenuate hepatic IRI via its anti‐inflammatory and antiapoptotic capacities. In this review, we discuss the potential mechanisms and current strategies of MT administration in liver surgery for protecting against warm or cold hepatic IRI. We highlight strategies to improve the efficacy and safety of MT for attenuating hepatic IRI in different conditions. After the potential mechanisms underlying the interactions between MT and other important cellular processes during hepatic IR are clarified, more opportunities will be available to use MT to treat liver diseases in the future.     

硒酸赖氨酸对四氧嘧啶诱发的小鼠肝损伤的防护作用

目的:研究硒酸赖氨酸对四氧嘧啶诱发的小鼠肝损伤的防护作用。方法:选取昆明小鼠50只,雌雄各半,随机分成五组,即对照组、模型组、低剂量组、中剂量组、高剂量组。采用四氧嘧啶致急性肝损伤模型,检测各组小鼠血清中谷丙转氨酶(ALT)、谷草转氨酶(AST)、碱性磷酸酶(AKP)活性,并对各组小鼠肝脏进行组织病理学观察。结果:硒酸赖氨酸能降低小鼠血清中ALT、AST、AKP活性(P<0.05或P<0.01),明显减轻四氧嘧啶致肝损伤小鼠肝细胞的病变及炎症反应。结论:硒酸赖氨酸具有对四氧嘧啶诱发小鼠肝损伤的保护作用。     

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Background

Hepatic fibrosis is a dynamic process which ultimately leads to cirrhosis in almost patients with chronic hepatic injury. However, progressive fibrosis is a reversible scarring response. Activation of hepatic stellate cells (HSCs) is the prevailing process during hepatic fibrosis. Osthole is an active component majorly contained in the fruit of Cnidium monnieri (L.) Cusson. This present study investigated the therapeutic effects of osthole on rat liver fibrosis and HSC activation.

Results

We established the thioacetamide (TAA)-model of Sprague–Dawley (SD) rats to induce hepatic fibrosis. Rats were divided into three groups: control, TAA, and TAA + osthole (10 mg/kg). In vivo, osthole significantly reduced liver injury by diminishing levels of plasma AST and ALT, improving histological architecture, decreasing collagen and α-SMA accumulation, and improving hepatic fibrosis scores. Additionally, osthole reduced the expression of fibrosis-related genes significantly. Osthole also suppressed the production of fibrosis-related cytokines and chemokines. Moreover, nuclear translocation of p65 was significantly suppressed in osthole-treated liver. Osthole also ameliorated TAA-induced injury through reducing cellular oxidation. Osthole showed inhibitory effects in inflammation-related genes and chemokines production as well. In vitro, we assessed osthole effects in activated HSCs (HSC-T6 and LX-2). Osthole attenuated TGF-β1-induced migration and invasion in HSCs. Furthermore, osthole decreased TNF-α-triggered NF-κB activities significantly. Besides, osthole alleviated TGF-β1- or ET-1-induced HSCs contractility.

Conclusions

Our study demonstrated that osthole improved TAA-caused liver injury, fibrogenesis and inflammation in rats. In addition, osthole suppressed HSCs activation in vitro significantly.

Electronic supplementary material

The online version of this article (doi:10.1186/s12929-015-0168-5) contains supplementary material, which is available to authorized users.     

注射用丹酚酸A防治肝纤维化的实验研究

目的：探讨注射用丹酚酸A抗肝纤维化的作用,为丹酚酸A的临床应用提供理论依据。方法采用CCl4体外诱导肝细胞损伤,观察丹酚酸A对肝细胞活性及其细胞培养上清液ALT、AST、LDH水平和细胞裂解液中SOD活性和MDA含量的变化;另采用皮下注射CCl4诱导大鼠肝纤维化模型,观察丹酚酸A对肝纤维化大鼠血清LN、HA、SOD和MDA含量的影响以及肝脏组织病理改变情况。结果与模型对照组比,丹酚酸A高、低剂量组和Vit E组的细胞存活率显著提高（P ＜0.01）,丹酚酸A高剂量组ALT、AST和LDH活性显著降低（P ＜0.01）,丹酚酸A高剂量组和Vit E组SOD活性明显升高（P ＜0.05）,MDA含量显著降低（P ＜0.05）;体内试验发现,与模型对照组比,丹酚酸A高剂量组纤维化大鼠的血清LN和HA水平显著降低（P ＜0.05）,高、低剂量组SOD活性显著升高（P ＜0.05, P ＜0.01）,MDA含量显著降低（P ＜0.01, P ＜0.05）,并能改善肝脏病理形态。结论注射用丹酚酸A可通过抗脂质过氧化作用,起到保护肝细胞,减轻肝纤维化的作用。     

Hepatoprotective activity of silymarin encapsulation against hepatic damage in albino rats

Liver fibrosis occurs due to liver injuries and toxins. Silymarin (SMR) extracted by the milk thistle seeds, is widely used such as herbal drug for its hepatoprotective properties. The purpose of this study to assess the properties of an optimized dose of encapsulated crude SMR on antidiabetic activity and liver fibrosis induced by paracetamol in male albino rat. Hepatic fibrosis was assessed by measuring liver enzymes. Results revealed that the consumption of encapsulated SMR, can effectively affluence the target and avoid the degradation of bioactive compound. Body weight of animal also significantly increased in each group during all the period. According to our optimized study, the long-term induction of SMR (300 mg/kg) significantly amplified survival time of rats with paracetamol induced hepatic injuries. The changes of liver fibrosis and the significant increase of hepatic enzyme biomarkers were also observed. In conclusion, the results suggest that SMR acts as a hepatoprotective agent by inhibiting the fibrogenisis and apoptosis in liver, as well as insulin resistance.     

Thy-1 is expressed in myofibroblasts but not found in hepatic stellate cells following liver injury

Thy-1 (CD90) is an adhesion molecule induced in fibroblast populations associated with wound healing and fibrosis. In this study the question whether Thy-1-gene-expression can be induced in hepatic stellate cells (HSC) in vivo, under conditions of liver injury or liver regeneration was addressed. Acute and chronic rat liver injury was induced by the administration of CCl₄. For comparison, cirrhotic human liver, and rat 67% partial hepatectomy (PH) was studied as well. Thy-1-gene-expression was examined also in isolated human liver myofibroblasts. Thy-1-mRNA expression was significantly upregulated in chronic liver injury. Thy-1⁺ cells were detected in the periportal area of rat liver specimens in normal-, injured- and regenerative-conditions. In chronic human and rat liver injury, Thy-1⁺ cells were located predominantly in scar tissue. In the pericentral necrotic zone after CCl₄-treatment, no induction of Thy-1 was found. Gremlin and Thy-1 showed comparable localization in the periportal areas. Thy-1 was not detected in either normal or capillarized sinusoids, in isolated rat HSC, and was neither inducible by inflammatory cytokines in isolated HSC, nor upregulated in treated myofibroblasts. Based upon these data Thy-1 is not a marker of “activated” sinusoidal HSC, but it is a marker of “activated” (myo)fibroblasts found in portal areas and in scar tissue. Electronic supplementary material  The online version of this article (doi:) contains supplementary material, which is available to authorized users.     

Role of heat shock protein 70 in hepatic ischemia-reperfusion injury in mice

It is well established that liver ischemia-reperfusion induces the expression of heat shock protein (HSP) 70. However, the biological function of HSP70 in this injury is unclear. In this study, we sought to determine the role of HSP70 in hepatic ischemia-reperfusion injury in mice. Male mice were subjected to 90 min of partial hepatic ischemia followed by up to 8 h of reperfusion. HSP70 was rapidly upregulated after reperfusion. To explore the function of HSP70, sodium arsenite (8 mg/kg iv) was injected before surgery. We found that this dose induced HSP70 expression within 6 h of treatment. Induction of HSP70 with arsenite resulted in a >50% reduction in liver injury as determined by serum transaminases and histology. In addition, arsenite similarly reduced liver neutrophil recruitment and liver nuclear factor-kappaB activation, and attenuated serum levels of tumor necrosis factor-alpha and macrophage inflammatory protein-2, but increased levels of interleukin (IL)-6. In HSP70 knockout mice, arsenite did not protect against liver injury but did reduce liver neutrophil accumulation. Arsenite-induced reductions in neutrophil accumulation in HSP70 knockout mice were found to be mediated by IL-6. To determine whether extracellular HSP70 contributed to the injury, recombinant HSP70 was injected before surgery. Intravenous injection of 10 microg of recombinant HSP70 had no effect on liver injury after ischemia-reperfusion. The data suggest that intracellular HSP70 is directly hepatoprotective during ischemia-reperfusion injury and that extracellular HSP70 is not a significant contributor to the injury response in this model. Targeted induction of HSP70 may represent a potential therapeutic option for postischemic liver injury.     

基质金属蛋白酶及其抑制剂在肝纤维化中的表达变化

目的 观察肝纤维化形成过程中基质金属蛋白酶MMP-1及其抑制剂TIMP-1的表达变化,从细胞外基质降解代谢的角度研究四氯化碳(CCl4)中毒性肝纤维化发生的机制.方法 雄性Wistar大鼠20只,分为正常组和肝纤维化模型组.肝纤维化组采用CCl4、饮酒、高脂低蛋白饮食等复合病因刺激制备肝纤维化动物模型,造模时间为8周.实验结束后测定肝脏指数、血清透明质酸(HA)、谷丙转氨酶(ALT)及尿羟脯氨酸(HYP)排出量,光镜下观察肝组织纤维化程度,并用免疫组化SABC法检测肝组织中Ⅰ、Ⅲ型胶原蛋白及MMP-1、TIMP-1的表达,同时用荧光实时定量PCR(RT-PCR)的方法检测肝组织中MMP-1、TIMP-1 mRNA的表达.结果 与正常对照组比较,肝纤维化模型组大鼠肝脏指数、血清HA及ALT显著增高,尿羟脯氨酸的排出量明显增加,病理组织学检查发现肝组织内纤维结缔组织增生明显,有假小叶形成;免疫组化的结果显示肝组织内Ⅰ、Ⅲ型胶原蛋白、MMP-1及TIMP-1的表达较正常组显著增加.结论 肝组织中MMP-1及TIMP-1的表达变化可能是导致肝纤维化的重要机制之一.     

Current knowledge on oxidative stress in hepatic ischemia/reperfusion

Abstract

Ischemia/reperfusion (I/R) injury associated with hepatic resections and liver transplantation remains a serious complication in clinical practice, despite several attempts to solve the problem. The redox balance, which is pivotal for normal function and integrity of tissues, is dysregulated during I/R, leading to an accumulation of reactive oxygen species (ROS). Formation of ROS and oxidant stress are the disease mechanisms most commonly invoked in hepatic I/R injury. The present review examines published results regarding possible sources of ROS and their effects in the context of I/R injury. We also review the effect of oxidative stress on marginal livers, which are more vulnerable to I/R-induced oxidative stress. Strategies to improve the viability of marginal livers could reduce the risk of dysfunction after surgery and increase the number of organs suitable for transplantation. The review also considers the therapeutic strategies developed in recent years to reduce the oxidative stress induced by hepatic I/R, and we seek to explain why some of them have not been applied clinically. New antioxidant strategies that have yielded promising results for hepatic I/R injury are discussed.     

Schistosoma japonicum soluble egg antigens induce apoptosis and inhibit activation of hepatic stellate cells: a possible molecular mechanism

Hepatic stellate cells play a key role in the development of hepatic fibrosis. Activated hepatic stellate cells can be reversed to a quiescent-like state or apoptosis can be induced to reverse fibrosis. Some studies have recently shown that Schistosoma mansoni eggs could suppress the activation of hepatic stellate cells and that soluble egg antigens from schistosome eggs could promote immunocyte apoptosis. Hence, in this study, we attempt to assess the direct effects of Schistosoma japonicum soluble egg antigens on hepatic stellate cell apoptosis, and to explore the mechanism by which the apoptosis of activated hepatic stellate cells can be induced by soluble egg antigens, as well as the mechanism by which hepatic stellate cell activation is inhibited by soluble egg antigens. Here, it was shown that S. japonicum-infected mouse livers had increased apoptosis phenomena and a variability of peroxisome proliferator-activated receptor γ expression. Soluble egg antigens induce morphological changes in the hepatic stellate cell LX-2 cell line, inhibit cell proliferation and induce cell-cycle arrest at the G₁ phase. Soluble egg antigens also induce apoptosis in hepatic stellate cells through the TNF-related apoptosis-inducing ligand/death receptor 5 and caspase-dependent pathways. Additionally, soluble egg antigens could inhibit the activation of hepatic stellate cells through peroxisome proliferator-activated receptor γ and the transforming growth factor β signalling pathways. Therefore, our study provides new insights into the anti-fibrotic effects of S. japonicum soluble egg antigens on hepatic stellate cell apoptosis and the underlying mechanism by which the liver fibrosis could be attenuated by soluble egg antigens.